|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-04
|
$700,207
|
$700,207
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S1
|
$25,000
|
$3,000
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S2
|
$709,079
|
$85,089
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-03
|
$2,300,000
|
$805,000
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA
|
4R00CA193734-03
|
$249,000
|
$124,500
|
SIKORA, MATTHEW
|
UNIVERSITY OF COLORADO DENVER
|
|
Wnt pathway dynamics in breast cancer metastasis
|
1K22CA207463-01
|
$188,042
|
$188,042
|
ROARTY, KEVIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
1P50CA211024-01A1
|
$2,184,999
|
$1,114,349
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
1F31CA213901-01A1
|
$44,044
|
$44,044
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-02
|
$2,143,077
|
$171,446
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-03
|
$332,363
|
$332,363
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
3U01CA196383-03S1
|
$312,000
|
$156,000
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VEGF signaling in Mammary Tumorigenesis
|
2R01CA168464-06
|
$397,813
|
$397,813
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Vascular communication in metastatic brain colonization
|
5R01CA184594-04
|
$321,625
|
$321,625
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,151,796
|
$345,539
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-02
|
$38,596
|
$38,596
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer
|
5R01CA195493-03
|
$255,891
|
$51,178
|
MORRIS, EVAN
|
YALE UNIVERSITY
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
5UH2CA206124-02
|
$248,101
|
$248,101
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-02
|
$1,537,769
|
$768,885
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
1R01CA217625-01
|
$646,803
|
$323,402
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Using the Collaborative Cross for Model Studies of Intestinal Cancer
|
5R21CA202496-02
|
$169,650
|
$42,413
|
SIRACUSA, LINDA
|
THOMAS JEFFERSON UNIVERSITY
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
1R21CA216756-01
|
$187,050
|
$187,050
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
1R21CA208921-01A1
|
$200,807
|
$200,807
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness
|
5R21CA201865-02
|
$179,438
|
$179,438
|
LIANG, GANGNING
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$27,615
|
$19,330
|
Merlino, Glenn
|
CCR (NCI)
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
5R01CA184804-02
|
$387,731
|
$387,731
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
|
5R01CA190642-03
|
$436,922
|
$218,461
|
BASELGA, JOSE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
|
5R21CA208609-02
|
$174,000
|
$174,000
|
PATEL, SAPNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Uniting Mass Spectrometry and Glycoscience to Investigate Cancer Biology
|
5F99CA212454-02
|
$32,109
|
$32,109
|
RILEY, NICHOLAS
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
3R01CA181633-04S1
|
$69,420
|
$69,420
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
5R01CA181633-04
|
$332,000
|
$332,000
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
|
1R01CA208100-01A1
|
$498,613
|
$498,613
|
CHEN, YU
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding the origin,initiation,and progression of high-grade serous ovarian cancer
|
5R00CA179137-04
|
$245,221
|
$122,611
|
KIM, JAEYEON
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Understanding the consequences of oncogenic mutations on FGFR signaling
|
1F31CA216915-01
|
$44,044
|
$22,022
|
RYAN, MOLLY
|
YALE UNIVERSITY
|
|
Understanding the AGL metastasis suppressor for therapeutic gain
|
3R01CA143971-07S1
|
$136,880
|
$136,880
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding the AGL metastasis suppressor for therapeutic gain
|
5R01CA143971-07
|
$435,425
|
$435,425
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer
|
1R01CA181671-01A1
|
$348,844
|
$174,422
|
SHAO, JIEYA
|
WASHINGTON UNIVERSITY
|
|
Understanding How Breast Cancers Activate and Respond to the Systemic Environment
|
5R01CA166284-06
|
$356,692
|
$178,346
|
MCALLISTER, SANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Understanding G alpha q/11 localization and trafficking in uveal melanoma
|
1F31CA224803-01
|
$44,044
|
$22,022
|
Randolph, Clinita
|
THOMAS JEFFERSON UNIVERSITY
|
|
Understanding Esophageal Adenocarcinoma Progression Using Inflammatory and Neoplastic Extracellular Matrix Hydrogels
|
5F31CA210694-02
|
$40,302
|
$20,151
|
SALDIN, LINDSEY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell
|
5F32CA210421-02
|
$56,694
|
$56,694
|
DANAI, LAURA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Understanding Breast Cancer Metastasis to Lymph Node
|
5R21CA199621-02
|
$168,563
|
$168,563
|
MOHAMMED, SULMA
|
PURDUE UNIVERSITY
|
|
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
|
1R01CA204969-01A1
|
$332,357
|
$332,357
|
NAGRATH, DEEPAK
|
UNIVERSITY OF MICHIGAN
|
|
Ultrasound imaging and enhanced therapeutic response
|
5R01CA134659-09
|
$499,000
|
$499,000
|
FERRARA, KATHERINE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis Network
|
5U24CA210990-02
|
$452,649
|
$226,325
|
STUART, JOSHUA
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
3R01CA193220-03S1
|
$51,321
|
$51,321
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-03
|
$352,275
|
$352,275
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
|
5R01CA175994-05
|
$322,663
|
$322,663
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
|
5R01CA200574-02
|
$359,138
|
$359,138
|
ZHANG, LIANGFANG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Tumor-stromal interactions as targets of tumor metastasis suppressors
|
5R01CA184494-03
|
$353,351
|
$353,351
|
ROSNER, MARSHA
|
UNIVERSITY OF CHICAGO
|
|
Tumor-initiating processes in luminal breast cancers
|
1F32CA213794-01A1
|
$56,694
|
$56,694
|
SELDIN, LINDSEY
|
VANDERBILT UNIVERSITY
|
Total relevant funding to Metastasis for this search: $322,237,548
|